Toward optimized 89Zr-immuno-PET: side-by-side comparison of (89Zr)Zr-DFO-, (89Zr)Zr-3,4,3-(LI-1,2-HOPO)- and (89Zr)Zr-DFO*-Cetuximab for tumor imaging : which chelator is the most suitable? - Damerow, Helen; Cheng, Xia; Kiedrowski, Valeska von; Schirrmacher, Ralf; Wängler, Björn; Fricker, Gert; Wängler, Carmen (Pharmaceutics, 2022)
Die 89 im Titel ist hochgestellt